Price Alert

AbbVie Inc. (ABBV)

NYSE: ABBV · Real-Time Price · USD

205.38

0.70 (0.34%)

At close: Aug 15, 2025, 12:05 PM

AbbVie Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	5.17B	5.52B	7.26B	13.13B	18.07B	12.81B	13.29B	8.76B	6.71B	9.2B	11.83B	8.52B	6.1B	9.75B	12.18B	8.55B	9.76B
Short-Term Investments	1M	31M	28M	27M	2M	2M	3M	7M	11M	28M	47M	1.44B	1.47B	84M	67M	54M	22M
Long-Term Investments	287M	279M	267M	272M	305M	304M	275M	288M	257M	241M	235M	244M	260M	277M	272M	266M	305M
Other Long-Term Assets	9.19B	9.14B	8.29B	9.2B	9.07B	8.51B	7.09B	6.2B	5.8B	5.57B	5.38B	5.03B	5.08B	4.88B	4.75B	4.81B	4.79B
Receivables	12.48B	10.92B	11.47B	11.72B	11.95B	11.15B	11.41B	11.49B	11.47B	11.25B	10.74B	11.24B	10.73B	9.98B	9.28B	9.91B	9.59B
Inventory	4.53B	4.18B	4.45B	4.22B	4.25B	4.1B	3.98B	4.05B	3.83B	3.58B	3.17B	3.4B	3.48B	3.13B	3.09B	3.39B	3.27B
Other Current Assets	5.5B	4.93B	4.58B	4.72B	4.61B	4.93B	4.54B	4.54B	4.46B	4.4B	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	27.68B	25.58B	27.79B	33.82B	38.87B	33B	33.22B	28.85B	26.49B	28.46B	30.36B	29.1B	26.51B	27.93B	28.96B	26B	26.57B
Property-Plant & Equipment	5.24B	5.13B	5.14B	5.02B	4.98B	4.99B	4.93B	4.94B	4.93B	4.93B	4.89B	4.96B	5.08B	5.11B	5.13B	5.16B	5.19B
Goodwill & Intangibles	93.77B	95.02B	101.94B	93.63B	95.65B	87.9B	90.69B	95.09B	97.07B	99.59B	100.45B	103.85B	106.28B	108.33B	109.75B	111.74B	113.64B
Total Long-Term Assets	108.49B	109.58B	115.64B	108.12B	110B	101.71B	103B	106.52B	108.06B	110.34B	110.96B	114.09B	116.7B	118.6B	119.9B	121.97B	123.93B
Total Assets	136.16B	135.16B	143.42B	141.94B	148.87B	134.71B	136.22B	135.37B	134.54B	138.81B	141.32B	143.19B	143.21B	146.53B	148.86B	147.97B	150.5B
Account Payables	30.96B	31.91B	30.4B	n/a	31.26B	3.69B	n/a	n/a	24.65B	2.93B	n/a	n/a	n/a	2.88B	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	5.36B	6.8B	12.57B	12.59B	10.2B	7.19B	5.12B	5.2B	2.8B	4.3B	9.21B	11.93B	9.95B	12.67B	6.67B	7.9B	11.35B
Other Current Liabilities	82M	35M	94M	29.33B	68M	134M	29.66B	27.04B	135M	20.93B	23.5B	22.54B	22.57B	17.85B	21.86B	20.78B	20.6B
Total Current Liabilities	36.4B	38.75B	43.06B	41.91B	41.52B	37.84B	34.77B	32.24B	27.59B	29.54B	32.71B	34.47B	32.52B	35.19B	28.53B	28.68B	31.95B
Long-Term Debt	64.53B	60.34B	58.51B	58.05B	63.8B	52.17B	55.63B	55.81B	59.29B	59.12B	60.4B	61B	63.52B	64.16B	74.05B	74.24B	74.18B
Other Long-Term Liabilities	31.19B	24.38B	33.03B	32.43B	32.78B	24.91B	31.64B	32.29B	32.25B	23.4B	30.21B	30.77B	28.02B	22.02B	29.1B	28.8B	26.87B
Total Long-Term Liabilities	98.3B	93.05B	94.29B	93.2B	99.31B	86.47B	89.32B	90.23B	93.65B	91.98B	92.59B	94.03B	94.38B	95.9B	106.75B	106.69B	104.82B
Total Liabilities	134.7B	131.8B	137.35B	135.12B	140.83B	124.31B	124.09B	122.47B	121.24B	121.52B	125.3B	128.5B	126.9B	131.09B	135.28B	135.38B	136.77B
Total Debt	69.89B	67.84B	71.08B	70.63B	74B	60.12B	60.75B	61.02B	62.09B	64.19B	69.61B	72.93B	73.47B	77.58B	80.72B	82.14B	85.53B
Common Stock	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M	18M
Retained Earnings	-9.53B	-7.9B	-4.96B	-3.77B	-2.38B	-1B	933M	1.79B	2.39B	4.78B	4.95B	3.52B	5.1B	3.13B	1.6B	740M	2.29B
Comprehensive Income	-1.74B	-1.93B	-2.33B	-2.51B	-2.45B	-2.31B	-2.35B	-2.25B	-2.23B	-2.2B	-3.44B	-3.2B	-2.98B	-2.9B	-3.16B	-3.1B	-3.29B
Shareholders Equity	1.42B	3.33B	6.03B	6.78B	8.01B	10.36B	12.09B	12.87B	13.27B	17.25B	15.99B	14.65B	16.28B	15.41B	13.55B	12.57B	13.71B
Total Investments	288M	310M	295M	299M	307M	306M	278M	295M	268M	269M	282M	1.68B	1.73B	361M	339M	320M	327M